The United States Supreme Court on May 17, 2021 denied certiorari, that is denied review of the $70 million verdict against Janssen, a Johnson & Johnson unit for Pennsylvania male who grew enlarged breast due to taking Risperdal.
Janssen Pharmaceuticals Inc. et al. v. A.Y. et al., # 20-1069, Supreme Court of the United States.
Forti Publications 